Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential

Clicks: 458
ID: 273331
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #11 of 148 articles by views in Toxins

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 148 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Serum therapy remains the only specific treatment against envenoming, but anti-venoms are still prepared by fragmentation of polyclonal antibodies isolated from hyper-immunized horse serum. Most of these anti-venoms are considered to be efficient, but their production is tedious, and their use may be associated with adverse effects. Recombinant antibodies and smaller functional units are now emerging as credible alternatives and constitute a source of still unexploited biomolecules capable of neutralizing venoms. This review will be a walk through the technologies that have recently been applied leading to novel antibody formats with better properties in terms of homogeneity, specific activity and possible safety.
Reference Key
alvarenga2014toxinsengineering Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Larissa M. Alvarenga;Muhammad Zahid;Anne Di Tommaso;Matthieu O. Juste;Nicolas Aubrey;Philippe Billiald;Julien Muzard;Alvarenga, Larissa M.;Zahid, Muhammad;Tommaso, Anne Di;Juste, Matthieu O.;Aubrey, Nicolas;Billiald, Philippe;Muzard, Julien;
Journal Toxins
Year 2014
DOI
10.3390/toxins6082541
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.